Mark Wilks
Impact in
- Microbiology top 2%
- Molecular Medicine top 2%
Papers in
- Epidemiology 32
- Urinary Tract Infections Management 7
-
- Clostridium difficile and Clostridium perfringens research 15
- Viral gastroenteritis research and epidemiology 7
- Co-authors
- Michael Millar (22 shared papers)S. Tabaqchali (22 shared papers)Gavin C. Donaldson (3 shared papers)Jadwiga A. Wedzicha (3 shared papers)Tom Wilkinson (4 shared papers)Irem Patel (2 shared papers)Kate Costeloe (8 shared papers)Pollyanna Hardy (5 shared papers)
- Journals
- Journal of Medical Microbiology (7 papers)Journal of Hospital Infection (6 papers)Journal of Antimicrobial Chemotherapy (5 papers)Journal of Clinical Microbiology (3 papers)Scientific Reports (2 papers)
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
Mark Wilks
91 papers receiving 3.1k citations
Mark Wilks's Hit Papers
Peers
Comparison fields: 5 of 136
- Microbiology 267
- Molecular Medicine 202
- Infectious Diseases 680
- Emergency Medical Services 260
- Clinical Biochemistry 247
Countries citing papers authored by Mark Wilks
This map shows the geographic impact of Mark Wilks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wilks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wilks more than expected).
Fields of papers citing papers by Mark Wilks
This network shows the impact of papers produced by Mark Wilks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wilks. The network helps show where Mark Wilks may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wilks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 337 | |
| 2 | 2003 | 284 | |
| 3 | Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial Hit paper breakdown → | 2015 | 276 |
| 4 | 2006 | 238 | |
| 5 | 2015 | 132 | |
| 6 | 2004 | 119 | |
| 7 | 2006 | 96 | |
| 8 | 2001 | 82 | |
| 9 | 2006 | 73 | |
| 10 | 2005 | 72 | |
| 11 | 2019 | 72 | |
| 12 | 2016 | 67 | |
| 13 | 1996 | 62 | |
| 14 | 2005 | 56 | |
| 15 | 1991 | 52 | |
| 16 | 2000 | 52 | |
| 17 | The role of infection on wound healing. | 1974 | 50 |
| 18 | 2013 | 49 | |
| 19 | 1995 | 47 | |
| 20 | 1978 | 47 |
About Mark Wilks
Mark Wilks is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Surgery and Nutrition and Dietetics, having authored 95 papers that have together received 3.2k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (15 papers), Bacterial Identification and Susceptibility Testing (12 papers), Antibiotic Resistance in Bacteria (12 papers), Infant Nutrition and Health (10 papers), Gut microbiota and health (9 papers), Urinary Tract Infections Management (7 papers), Viral gastroenteritis research and epidemiology (7 papers) and Probiotics and Fermented Foods (7 papers). The work is most often cited by research in Microbiology (267 citations), Molecular Medicine (202 citations), Infectious Diseases (680 citations), Emergency Medical Services (260 citations) and Clinical Biochemistry (247 citations). Mark Wilks has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Michael Millar, S. Tabaqchali, Gavin C. Donaldson, Jadwiga A. Wedzicha, Tom Wilkinson, Irem Patel, Kate Costeloe, Pollyanna Hardy, Edmund Juszczak and Peter Mullany. Their work appears in journals such as Journal of Medical Microbiology, Journal of Hospital Infection, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.